The Multiplex PCR Company
Multiplex qPCR implemented on the walk-away ICEPlex instrument — Truly, a Next Generation qPCR Platform
Find the Application that Interests You »Who is PrimeraDx?
PrimeraDx is a molecular diagnostics company that has developed, and is commercializing the ICEPlex system, a novel, game-changing clinical platform which combines PCR with capillary electrophoresis.
The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative, answers to the clinic.
The company is pursuing a two-pronged strategy to sell the system in an Open Platform Mode to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion and enabling diagnostic products.
Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes.
PrimeraDx’s technology represents the next generation of quantitative PCR.
PrimeraDx is ISO 13485: 2003 certified.
Visit Us At
-
BD Biotech Conference
- Boston, MA
- April 2–3, 2013
-
BIO International Convention
- Chicago, IL
- April 22–25, 2013
-
BIT's 4th Annual World DNA and Genome Day - 2013
- Nanjing, China
- April 25–27, 2013
-
Clinical Virology Symposium
- Daytona Beach, FL
- April 26–May 1, 2013
-
TieCon East: Empowering Entrepeneurs
- Cambridge, MA
- May 2–April 3, 2013
-
American Society of Clinical Oncology
- Chicago, IL
- May 31–June 4, 2013Booth #4096
-
MDx Cancer Drug Development
- Boston, MA
- June 18–20, 2013
-
AACC Annual Meeting
- Houston, TX
- July 28–August 1, 2013
-
Next Generation Dx Summit
- Washington, D.C.
- August 20–22, 2013
-
Lab Institute 2013
- Arlington, VA
- October 16–18, 2013
-
Association for Molecular Pathology Annual Meeting
- Phoenix, AZ
- November 13–16, 2013
-
World CDx Summit
- Boston, MA
- November 19–21, 2013